Group One Trading
MYGN icon

Group One Trading’s Myriad Genetics MYGN Stock Holding History

Group One Trading’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,500
Closed -$169K – 8343
2025
Q4 		$169K Sell
27,500
-5,500
-17% -$39.9K ﹤0.01% 4529
2025
Q3 		$239K Buy
33,000
+32,500
+6,500% +$193K ﹤0.01% 4491
2025
Q2 		$2.65K Buy
500
+400
+400% +$2.36K ﹤0.01% 7318
2025
Q1 		$887 Sell
100
-1,400
-93% -$16.8K ﹤0.01% 7197
2024
Q4 		$20.6K Sell
1,500
-4,400
-75% -$81.2K ﹤0.01% 5667
2024
Q3 		$162K Buy
5,900
+4,800
+436% +$130K ﹤0.01% 3809
2024
Q2 		$26.9K Sell
1,100
-1,300
-54% -$28.5K ﹤0.01% 5009
2024
Q1 		$51.2K Sell
2,400
-2,000
-45% -$43K ﹤0.01% 4700
2023
Q4 		$84.2K Sell
4,400
-43,000
-91% -$744K ﹤0.01% 4605
2023
Q3 		$760K Buy
47,400
+1,000
+2% +$19K ﹤0.01% 2532
2023
Q2 		$1.08M Buy
46,400
+33,300
+254% +$727K ﹤0.01% 2296
2023
Q1 		$304K Buy
13,100
+1,500
+13% +$30.5K ﹤0.01% 3263
2022
Q4 		$168K Buy
+11,600
New +$216K ﹤0.01% 3999
2022
Q3 		– Sell
-3,800
Closed -$69K – 7988
2022
Q2 		$69K Hold
3,800
– – ﹤0.01% 5298
2022
Q1 		$96K Sell
3,800
-4,800
-56% -$123K ﹤0.01% 5529
2021
Q4 		$237K Sell
8,600
-1,400
-14% -$40.6K ﹤0.01% 4919
2021
Q3 		$323K Sell
10,000
-400
-4% -$13.3K ﹤0.01% 4665
2021
Q2 		$318K Sell
10,400
-47,000
-82% -$1.36M ﹤0.01% 4734
2021
Q1 		$1.75M Buy
57,400
+18,000
+46% +$511K ﹤0.01% 2619
2020
Q4 		$779K Buy
39,400
+28,200
+252% +$455K ﹤0.01% 2867
2020
Q3 		$146K Buy
11,200
+2,700
+32% +$34.2K ﹤0.01% 3896
2020
Q2 		$96K Sell
8,500
-2,300
-21% -$32.7K ﹤0.01% 3945
2020
Q1 		$155K Buy
10,800
+9,000
+500% +$190K ﹤0.01% 2952
2019
Q4 		$49K Sell
1,800
-600
-25% -$16.5K ﹤0.01% 4009
2019
Q3 		$69K Sell
2,400
-41,200
-94% -$1.2M ﹤0.01% 3805
2019
Q2 		$1.21M Buy
+43,600
New +$1.23M 0.01% 1467
2019
Q1 		– Sell
-100
Closed -$3K – 5162
2018
Q4 		$3K Sell
100
-5,600
-98% -$201K ﹤0.01% 4588
2018
Q3 		$262K Buy
5,700
+5,300
+1,325% +$236K ﹤0.01% 2812
2018
Q2 		$15K Sell
400
-15,400
-97% -$520K ﹤0.01% 4487
2018
Q1 		$467K Buy
15,800
+9,400
+147% +$318K ﹤0.01% 2116
2017
Q4 		$220K Sell
6,400
-7,300
-53% -$246K ﹤0.01% 2864
2017
Q3 		$496K Sell
13,700
-43,000
-76% -$1.23M ﹤0.01% 2078
2017
Q2 		$1.47M Buy
56,700
+52,100
+1,133% +$1.11M 0.02% 1171
2017
Q1 		$88K Buy
4,600
+200
+5% +$3.54K ﹤0.01% 3055
2016
Q4 		$73K Sell
4,400
-9,100
-67% -$165K ﹤0.01% 3023
2016
Q3 		$278K Buy
13,500
+3,700
+38% +$93.8K ﹤0.01% 2247
2016
Q2 		$300K Buy
9,800
+3,700
+61% +$129K ﹤0.01% 2121
2016
Q1 		$228K Sell
6,100
-87,200
-93% -$3.29M ﹤0.01% 2234
2015
Q4 		$4.03M Buy
93,300
+12,900
+16% +$545K 0.05% 465
2015
Q3 		$3.01M Sell
80,400
-7,300
-8% -$259K 0.04% 570
2015
Q2 		$2.98M Buy
87,700
+21,600
+33% +$734K 0.04% 532
2015
Q1 		$2.34M Sell
66,100
-94,500
-59% -$3.38M 0.04% 563
2014
Q4 		$5.47M Sell
160,600
-93,700
-37% -$3.32M 0.08% 256
2014
Q3 		$9.81M Sell
254,300
-64,400
-20% -$2.4M 0.15% 117
2014
Q2 		$12.4M Sell
318,700
-84,400
-21% -$3.14M 0.19% 80
2014
Q1 		$13.8M Buy
403,100
+49,500
+14% +$1.53M 0.23% 67
2013
Q4 		$7.42M Buy
353,600
+326,700
+1,214% +$8.26M 0.11% 164
2013
Q3 		$632K Sell
26,900
-51,000
-65% -$1.45M 0.01% 1410
2013
Q2 		$2.09M Buy
+77,900
New +$2.26M 0.05% 404

Other funds holding MYGN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading's MYGN Position: Q3 2025 in Review

Group One Trading sold out of Myriad Genetics (MYGN) in Q3 2025, closing a stake of 7,577 shares — an estimated $45K sold.

Group One Trading first reported a position in MYGN in Q3 2014 and held it in 29 quarters. The position peaked at $1.89M in Q1 2015. 221 funds tracked by Wall St. Rank hold MYGN as of Q3 2025.

  • Group One Trading reported no remaining Myriad Genetics position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 7,577 Myriad Genetics shares in Q3 2025, an estimated $45K.
  • Group One Trading first reported a position in Myriad Genetics in Q3 2014 and held it in 29 quarters.
  • Group One Trading's Myriad Genetics position peaked at $1.89M in Q1 2015.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.